Elective Induction and C-Section: What the Research Shows

Labor hormones Elective induction Cascade of interventions Fetal monitoring Epidurals & breastfeeding Microbiome Cesarean risks Midwife-led care Questions to ask FAQ Sources

Elective induction and cesarean birth are two of the most common decisions in maternity care. This article covers what the trials and cohort studies show about induction timing, the interventions that tend to follow one another during a hospital labor, epidurals and breastfeeding, the newborn microbiome, cesarean risks for mother and baby, and the outcomes of midwife-led care. My own views on how these procedures are used are on my Substack, linked at the end.

Key takeaways

• In the largest randomized trial to date, induction at 39 weeks in low-risk first-time mothers lowered the cesarean rate compared with waiting, with no difference in newborn outcomes.
• Stillbirth risk rises with each week past 40, though the absolute numbers stay small: about one additional stillbirth for every 1,449 pregnancies that continue from 40 to 41 weeks.
• Continuous electronic fetal monitoring raises the cesarean rate by about 63 percent compared with intermittent listening, halves newborn seizures, and leaves death and cerebral palsy rates unchanged.
• Evidence on epidurals and breastfeeding is split. A large observational cohort found lower breastfeeding at six weeks, while a randomized trial found no effect from fentanyl dose.
• Each additional cesarean raises the risk of placenta accreta, from 0.24 percent at a first surgery to 6.74 percent at a sixth.
• Midwife continuity of care reduces cesarean and instrumental births in randomized trials.

This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Decisions about induction, pain relief, and mode of birth belong with you and your prenatal care provider. Nothing here is a reason to decline care recommended for a specific medical condition.

How Labor Hormones Work

Evidence: moderate. Systematic review of 20 studies measuring oxytocin in laboring women.

Oxytocin drives contractions. A 2019 systematic review of plasma oxytocin studies found that baseline levels rise three to four fold during pregnancy, and that oxytocin is released in pulses that grow in frequency, length, and strength as labor advances, reaching about three pulses every ten minutes near the end.¹ Synthetic oxytocin (Pitocin) delivered by IV raises blood levels continuously rather than in pulses. The same review notes that oxytocin released inside the brain during labor is regulated separately from oxytocin in the blood, and that the synthetic form given intravenously enters the brain only in very small amounts.¹ Oxytocin acting in the brain is linked to pain tolerance, calm, and bonding, so a labor run on synthetic oxytocin produces contractions without the same central effects.

Labor also prepares the baby's lungs. The stress hormones of late labor help clear fluid from the airways, which is one reason babies born by planned cesarean before labor begins have higher rates of breathing problems, covered in the risks section below. Prolactin, the milk-making hormone, rises through late pregnancy and labor as well, and skin-to-skin contact right after birth supports the transition to breastfeeding.

Elective Induction: What the Trials Show

Evidence: strong. One large randomized trial and a meta-analysis of 13 cohort studies covering 15 million pregnancies.

Elective induction means starting labor with medication when there is no medical reason to deliver early. The best data on it comes from the ARRIVE trial, published in 2018 and funded by the US National Institute of Child Health and Human Development. Researchers randomized 6,106 low-risk first-time mothers to either induction at 39 weeks or waiting for labor to begin on its own. The cesarean rate was 18.6 percent in the induction group and 22.2 percent in the waiting group. A combined measure of newborn death or serious complications was 4.3 percent versus 5.4 percent, a difference that did not reach statistical significance.²

Only 27 percent of eligible women agreed to be randomized, so participants were women who were comfortable with either path, and the trial did not report how those who declined differed. The waiting group's protocol allowed no elective induction before 40 weeks 5 days and required delivery by 42 weeks 2 days, so it describes standard hospital management rather than a low-intervention model. All 41 sites had round-the-clock in-house obstetric coverage, which smaller hospitals and birth centers may not match. Even so, the trial does not support the idea that elective induction at 39 weeks raises the cesarean rate in low-risk first-time mothers.

Pregnancy continuing past 40 weeks carries its own risk. A 2019 meta-analysis of 13 cohort studies covering 15 million pregnancies found that stillbirth risk rises with each week at term, from 0.11 per 1,000 pregnancies at 37 weeks to 3.18 per 1,000 at 42 weeks. Continuing from 40 to 41 weeks produced one additional stillbirth for every 1,449 pregnancies. Newborn death rates did not change until 42 weeks, when they rose compared with 41.³ The absolute risk stays low at every week, and the authors caution that the studies varied in how they defined a low-risk pregnancy.

Both figures depend on an accurate due date. Most due dates are counted from the last menstrual period, which assumes ovulation on day 14. Women who ovulate later than that are assigned a due date earlier than the true one, so their "41 weeks" may be 40 or less. Charting ovulation with the symptothermal method before conception gives a far more accurate date to work from, and early ultrasound dating is the clinical alternative.

The Cascade of Interventions

Evidence: moderate. Cochrane reviews and one cohort of 62,415 labors; the sequence itself is a documented clinical pattern rather than a trial outcome.

The phrase "cascade of interventions" describes a pattern in which one procedure changes the conditions of labor in a way that makes the next procedure more likely. Any single step in the sequence can be the right call for a given labor. The pattern describes how often the steps cluster together.

Synthetic oxytocin

Induction typically begins with cervical ripening followed by Pitocin through an IV. Because the drug arrives continuously rather than in the body's pulses, contractions are often stronger and closer together than in spontaneous labor, and the central oxytocin effects that help with pain tolerance are reduced.¹ Stronger contractions increase the likelihood that a woman will request pain relief.

The epidural

A labor epidural is a catheter placed in the space around the spinal cord, delivering a low-dose local anesthetic (bupivacaine or ropivacaine in most US hospitals) usually combined with a small amount of the opioid fentanyl. It removes most sensation below the waist. That relief comes with reduced mobility, and upright positions and movement are among the simplest tools for helping a baby descend through the pelvis. When contractions are strong but the mother cannot move or feel the urge to push, labor can slow, which is recorded as "failure to progress."

Time limits and the labor curve

Whether a labor counts as slow depends on which timeline the hospital uses. Many protocols still trace back to the Friedman curve, a dilation timeline built from 1950s data. A 2010 study from the Consortium on Safe Labor, funded by the US National Institute of Child Health and Human Development, examined 62,415 labors that ended with a healthy baby and found that dilation from 4 to 6 centimeters took far longer than the older standards allowed, and that labor did not reliably speed up until 6 centimeters.⁴ A woman judged against the older curve can be labeled as stalled while progressing normally by the newer data.

Breaking the waters

If labor slows, a provider may rupture the amniotic sac by hand to speed contractions. Once the membranes are open, infection risk climbs with time, which sets a time limit on the rest of the labor.

Food and fluids

Most US hospitals limit laboring women to clear liquids or ice chips, a policy that dates from an era when general anesthesia for birth was common and aspiration was a real concern. A Cochrane review of five trials with 3,130 women found no evidence of benefit or harm from restricting food and drink in women at low risk of needing general anesthesia, and the authors concluded that these women should be free to eat and drink as they wish.⁵

Continuous Electronic Fetal Monitoring

Evidence: strong for the cesarean effect, though rated low certainty by the reviewers. Cochrane review of 13 randomized trials with more than 37,000 women.

Continuous monitoring straps two sensors to the abdomen to record the baby's heart rate and the contraction pattern without interruption. The alternative, intermittent auscultation, means listening to the baby's heart at set intervals with a handheld Doppler. A 2017 Cochrane review compared the two across 13 trials. Continuous monitoring raised the cesarean rate by 63 percent (relative risk 1.63) and the rate of forceps or vacuum births by 15 percent. Rates of perinatal death and cerebral palsy did not differ. Continuous monitoring did halve the rate of newborn seizures.⁶

The reviewers rated the cesarean evidence as low certainty because two-thirds of the data came from a single 1985 Dublin trial where the overall cesarean rate was 2.3 percent, far below current practice. The finding has held across every update of the review since 2006. Continuous monitoring also keeps the mother in or near the bed, which feeds back into the mobility problem described above. Wireless and intermittent options exist and are worth asking about.

Epidurals and Breastfeeding

Evidence: mixed. Two large prospective cohorts and two randomized trials reach different conclusions; a systematic review of 23 studies found no consensus.

Studies on epidurals and breastfeeding reach different conclusions, partly because they measure different populations and different doses.

On the side of an effect, a 2019 prospective cohort of 1,204 women in Israel who intended to breastfeed found that 74.0 percent of those who had an epidural were still breastfeeding at six weeks compared with 83.4 percent of those who did not. After adjusting for 14 variables including parity, the epidural was associated with a 40 percent lower likelihood of breastfeeding at six weeks.⁷ A 2005 randomized double-blind trial of 177 women in New York compared epidurals with no fentanyl, low-dose fentanyl, and high-dose fentanyl. Women who received more than 150 micrograms of fentanyl were more likely to have stopped breastfeeding by six weeks.⁸ A 2006 Australian cohort of 1,280 women found that those with epidurals were more likely to be partially rather than fully breastfeeding in the first week and more likely to stop within 24 weeks.¹⁰

On the other side, a 2017 randomized double-blind trial of 345 women at Northwestern University, designed to test the 2005 finding, assigned participants to epidurals with zero, low, or high fentanyl concentrations. Breastfeeding at six weeks was 97, 98, and 94 percent across the three groups, with no significant difference, and fentanyl levels in umbilical cord blood did not predict who stopped.⁹ The women in that trial had all breastfed a previous child successfully, which may explain the high rates and limits how far the result applies to first-time mothers.

A 2016 systematic review in the Journal of Human Lactation examined 23 studies and found 12 with a negative association, 10 with no association, and one with a positive association.¹¹ The reviewers pointed to inconsistent study designs and unmeasured confounders. Skin-to-skin contact in the first hour, lactation support in the hospital, and how soon a mother returns to work all shape breastfeeding outcomes and were not controlled in most of the studies. An epidural may make establishing breastfeeding harder for some women, and fentanyl dose has not been shown to be the mechanism in the best-designed trial. Early skin-to-skin contact and good lactation support are the factors within a family's control.

Handmade in Montana

← →

The Newborn Microbiome

Evidence: strong for the difference in early colonization; associations with later disease are observational and do not prove cause.

A baby's first bacteria come from the birth itself. In a 2010 study published in PNAS, researchers sampled newborns within minutes of delivery and found that vaginally born babies carried bacterial communities resembling their mother's vaginal flora, dominated by Lactobacillus, while cesarean-born babies carried communities resembling skin, dominated by Staphylococcus, Corynebacterium, and Propionibacterium.¹²

The largest follow-up study to date, published in Nature in 2019, sequenced stool samples from 596 babies in the United Kingdom across the first year. Cesarean-born babies were missing the Bacteroides strains normally passed from mother to child, and were instead colonized by hospital-associated species including Enterococcus, Enterobacter, and Klebsiella. The gap narrowed over infancy but did not close completely. The same pattern appeared to a smaller degree in vaginally born babies whose mothers received antibiotics during labor and in babies who were not breastfed.¹³

Whether these early differences cause later disease is still an open question. A Danish registry study of two million children born between 1977 and 2012 found that cesarean birth was associated with higher rates of asthma, systemic connective tissue disorders, juvenile arthritis, inflammatory bowel disease, immune deficiencies, and leukemia.¹⁴ Registry studies of this kind show association only. Families who have cesareans may differ from those who do not in ways the records cannot capture, and no trial has tested the microbiome as the mechanism. Vaginal seeding, in which a cesarean-born baby is swabbed with the mother's vaginal fluid, is an experimental attempt to close the gap and has not yet been shown to change health outcomes.

Cesarean Risks for Baby and Mother

Evidence: strong. Two large prospective cohorts, one of 34,458 deliveries and one of 30,132 cesareans.

For the baby

Passing through the birth canal and the hormonal surge of labor both help clear fluid from a baby's lungs. Babies delivered by planned cesarean before labor begins miss that process. A Danish cohort of 34,458 deliveries found that, compared with babies whose mothers intended a vaginal birth, those delivered by elective cesarean at 37 weeks had 3.9 times the odds of respiratory problems such as transient tachypnea and respiratory distress syndrome. The odds were 3.0 times higher at 38 weeks and 1.9 times higher at 39 weeks, and the pattern held after excluding pregnancies with diabetes, preeclampsia, growth restriction, or breech presentation.¹⁵ This is the main reason planned cesareans are now scheduled at 39 weeks or later when there is no reason to deliver sooner.

For the mother

A cesarean is major abdominal surgery, with the recovery, infection risk, blood loss, and clotting risk that surgery carries. The risk least often discussed before a first cesarean is what it does to future pregnancies. Each incision leaves scar tissue on the uterus, and a placenta that implants over that scar can grow into or through the uterine wall, a condition called placenta accreta spectrum. Accreta can cause life-threatening bleeding and often requires removal of the uterus.

A prospective cohort of 30,132 women who had cesareans at 19 US academic centers, funded by the US National Institute of Child Health and Human Development, measured how the risk climbs. Placenta accreta occurred in 0.24 percent of first cesareans, 0.31 percent of second, 0.57 percent of third, 2.13 percent of fourth, 2.33 percent of fifth, and 6.74 percent of sixth or later. Hysterectomy was needed in 0.65 percent of first cesareans and 8.99 percent of sixth or later. Among women who also had placenta previa, accreta risk rose from 3 percent at a first cesarean to 67 percent at a fifth.¹⁶ The authors concluded that the number of children a woman hopes to have should be part of the conversation before any elective cesarean.

Midwife Continuity of Care

Evidence: strong. Cochrane review of 17 randomized trials with 18,533 women, updated in 2024.

Midwife continuity of care means the same midwife or small team provides care through pregnancy, birth, and the early postpartum weeks. A 2024 Cochrane review pooled 17 randomized trials conducted in Australia, Canada, China, Ireland, and the United Kingdom. Compared with other models, midwife continuity of care reduced cesarean births from 16 to 15 percent (relative risk 0.91), reduced forceps and vacuum births, and increased spontaneous vaginal birth. It may also reduce episiotomy. Women in these models reported more positive experiences of care, and costs were lower during pregnancy and birth. Rates of fetal loss, preterm birth, and newborn death did not differ.¹⁷

Most of the women in these trials were at low risk of complications, so the results describe healthy pregnancies rather than high-risk ones. In the United States, midwifery care is provided by certified nurse-midwives, certified midwives, and certified professional midwives, and what each may do varies by state. Longer prenatal visits, consistent relationships, and support for movement and position changes in labor are common features of the model, and many hospital systems now offer midwife-led care alongside obstetric care.

Questions to Ask Your Provider

Evidence: not applicable. These questions are drawn from the studies above.

Informed consent means understanding what a procedure does, what the alternatives are, and what the trade-offs look like for you and your baby. The first set of questions is for a consultation before you commit to a provider or practice. The second set is for the appointment where an induction or cesarean is recommended.

When choosing a provider

• What percentage of your patients' births end in cesarean, and what percentage of your patients are induced? Does the practice track those numbers?
• Do you support physiological birth, meaning labor that starts on its own and proceeds without routine intervention unless a problem develops?
• Who will be at my birth? Will it be you, someone from a small team I will have met, or whoever is on call?
• How long are prenatal visits, and how much of each visit is time to ask questions?
• At what gestational age do you routinely recommend induction for a healthy pregnancy, and what is that recommendation based on?
• For a low-risk labor, do you use intermittent listening with a handheld Doppler or continuous electronic monitoring? Is wireless monitoring available?
• Can I eat and drink during labor?
• Which labor curve does your practice or hospital use to define slow progress, and how long will you wait before recommending Pitocin or a cesarean?
• Which positions can I labor and push in? Is water immersion available?
• After birth, is immediate skin-to-skin contact standard, including after a cesarean?
• If I have had a cesarean before, do you attend vaginal births after cesarean, and what is your success rate?

When an induction or cesarean is recommended

• Is my due date calculated from my last menstrual period, from my date of conception, or from an early ultrasound? If it was from my last period, how regular was my cycle assumed to be?
• What is the medical reason for this recommendation, and what specific outcome are you trying to prevent?
• What happens if we wait? How does the risk change in absolute numbers if we wait three days, or a week?
• Is there a test we can do first, such as a nonstress test, an ultrasound of fluid levels, or a growth scan, that would tell us whether waiting is safe?
• If I decline today, what monitoring would you recommend in the meantime, and at what point would you want to revisit the decision?
• Given the state of my cervix, what is the chance this induction ends in a cesarean?
• Which induction method are you proposing, and what does each step involve? Can we start with a less intensive step such as a Foley balloon before Pitocin?
• Can I still move, eat, and use intermittent monitoring during an induction?
• If this is a cesarean, is it urgent, or can it be scheduled at 39 weeks or later?
• How will this cesarean affect my future pregnancies, and how many children do I hope to have?
• Is there time to get a second opinion?

Frequently Asked Questions

Does elective induction at 39 weeks increase the chance of a C-section?

Not according to the largest randomized trial. In 6,106 low-risk first-time mothers, induction at 39 weeks resulted in an 18.6 percent cesarean rate compared with 22.2 percent for those who waited for labor.² The trial ran at hospitals with round-the-clock in-house obstetric coverage, and participants had agreed to either path.

How much does stillbirth risk rise after 40 weeks?

Across 15 million pregnancies, stillbirth risk rose from 0.11 per 1,000 at 37 weeks to 3.18 per 1,000 at 42 weeks. Continuing from 40 to 41 weeks produced about one additional stillbirth per 1,449 pregnancies.³

Do epidurals affect breastfeeding?

The evidence is split. A 2019 cohort of 1,204 women found lower breastfeeding at six weeks with an epidural, while a 2017 randomized trial found no effect from fentanyl dose in women who had breastfed before. A review of 23 studies found 12 negative, 10 neutral, and one positive.^{7, 9, 11} Early skin-to-skin contact and lactation support matter regardless of pain relief choice.

Does each C-section make the next one riskier?

Yes. Placenta accreta risk rises from 0.24 percent at a first cesarean to 6.74 percent at a sixth or later, and hysterectomy risk rises from 0.65 percent to 8.99 percent over the same range.¹⁶

Sources

1. Uvnäs-Moberg K, Ekström-Bergström A, Berg M, et al. Maternal plasma levels of oxytocin during physiological childbirth: a systematic review with implications for uterine contractions and central actions of oxytocin. BMC Pregnancy Childbirth. 2019;19:285. doi:10.1186/s12884-019-2365-9 · PubMed ↩
2. Grobman WA, Rice MM, Reddy UM, et al. Labor induction versus expectant management in low-risk nulliparous women (ARRIVE). N Engl J Med. 2018;379(6):513-523. Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development. doi:10.1056/NEJMoa1800566 · PubMed ↩
3. Muglu J, Rather H, Arroyo-Manzano D, et al. Risks of stillbirth and neonatal death with advancing gestation at term: a systematic review and meta-analysis of cohort studies of 15 million pregnancies. PLoS Med. 2019;16(7):e1002838. doi:10.1371/journal.pmed.1002838 · PubMed ↩
4. Zhang J, Landy HJ, Branch DW, et al; Consortium on Safe Labor. Contemporary patterns of spontaneous labor with normal neonatal outcomes. Obstet Gynecol. 2010;116(6):1281-1287. Authors affiliated with the Eunice Kennedy Shriver National Institute of Child Health and Human Development. doi:10.1097/AOG.0b013e3181fdef6e · PubMed ↩
5. Singata M, Tranmer J, Gyte GML. Restricting oral fluid and food intake during labour. Cochrane Database Syst Rev. 2013;(8):CD003930. doi:10.1002/14651858.CD003930.pub3 ↩
6. Alfirevic Z, Devane D, Gyte GML, Cuthbert A. Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database Syst Rev. 2017;(2):CD006066. doi:10.1002/14651858.CD006066.pub3 ↩
7. Orbach-Zinger S, Landau R, Davis A, et al. The effect of labor epidural analgesia on breastfeeding outcomes: a prospective observational cohort study in a mixed-parity cohort. Anesth Analg. 2019;129(3):784-791. doi:10.1213/ANE.0000000000003442 · PubMed ↩
8. Beilin Y, Bodian CA, Weiser J, et al. Effect of labor epidural analgesia with and without fentanyl on infant breast-feeding: a prospective, randomized, double-blind study. Anesthesiology. 2005;103(6):1211-1217. doi:10.1097/00000542-200512000-00016 · PubMed ↩
9. Lee AI, McCarthy RJ, Toledo P, Jones MJ, White N, Wong CA. Epidural labor analgesia-fentanyl dose and breastfeeding success: a randomized clinical trial. Anesthesiology. 2017;127(4):614-624. doi:10.1097/ALN.0000000000001793 · PubMed ↩
10. Torvaldsen S, Roberts CL, Simpson JM, Thompson JF, Ellwood DA. Intrapartum epidural analgesia and breastfeeding: a prospective cohort study. Int Breastfeed J. 2006;1:24. doi:10.1186/1746-4358-1-24 · PMC ↩
11. French CA, Cong X, Chung KS. Labor epidural analgesia and breastfeeding: a systematic review. J Hum Lact. 2016;32(3):507-520. doi:10.1177/0890334415623779 · PubMed ↩
12. Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA. 2010;107(26):11971-11975. doi:10.1073/pnas.1002601107 · PubMed ↩
13. Shao Y, Forster SC, Tsaliki E, et al. Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth. Nature. 2019;574(7776):117-121. doi:10.1038/s41586-019-1560-1 · PubMed ↩
14. Sevelsted A, Stokholm J, Bønnelykke K, Bisgaard H. Cesarean section and chronic immune disorders. Pediatrics. 2015;135(1):e92-e98. doi:10.1542/peds.2014-0596 · PubMed ↩
15. Hansen AK, Wisborg K, Uldbjerg N, Henriksen TB. Risk of respiratory morbidity in term infants delivered by elective caesarean section: cohort study. BMJ. 2008;336(7635):85-87. doi:10.1136/bmj.39405.539282.BE · PubMed ↩
16. Silver RM, Landon MB, Rouse DJ, et al; NICHD Maternal-Fetal Medicine Units Network. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 2006;107(6):1226-1232. Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development. doi:10.1097/01.AOG.0000219750.79480.84 · PubMed ↩
17. Sandall J, Fernandez Turienzo C, Devane D, et al. Midwife continuity of care models versus other models of care for childbearing women. Cochrane Database Syst Rev. 2024;(4):CD004667. doi:10.1002/14651858.CD004667.pub6 · PubMed ↩